Phase IIb randomized, blinded, controlled trial evaluating neoadjuvant PD-1 blockade combined with A2B5<sup>+</sup> glioma stem-like cell lysate-loaded DC vaccine in recurrent glioblastoma (IDH1/2 -).
Yu Yao(Qinghai University), Liangfu Zhou(Fudan University), Chenwei Li, Chunxia Ji(Shanghai Public Health Clinical Center), Xiaoming Huang(Nanchong Central Hospital), Lang Hu(Sun Yat-sen University), Yuan Wang(Sichuan University), Di Chen(Fudan University), Nan Zhou(Chinese Academy of Sciences), Lingchao Chen(Allen Institute for Brain Science), Dave S.�B. Hoon(Saint John's Health Center)
Cited by 2
Related Papers
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
Temozolomide-associated hypermutation in gliomas
|Neuro-Oncology|2018|227